Gefitinib-induced intestinal obstruction in advanced non-small cell lung carcinoma: A case report

Author： Liang YiChen   Wu Gang   Cheng Jing   Yu DanDan   Wu HongGe  

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|3|1277-1280

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.3, 2015-09, pp. : 1277-1280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

By                  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report

By              

Experimental and Therapeutic Medicine, Vol. 10, Iss. 1, 2015-01 ,pp. : 386-388

Spandidos Publications

Access to resources Recommend Favorite

Rechallenge with gefitinib following severe druginduced hepatotoxicity in a patient with advanced nonsmall cell lung cancer: A case report and literature review

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 878-880

Spandidos Publications

Access to resources Recommend Favorite

High efficacy of gefitinib in the treatment of EGFR mutationpositive advanced nonsmall cell lung adenocarcinoma: A case report

By    

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1320-1322

Spandidos Publications

Access to resources Recommend Favorite

Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

By Gatineau M.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 114-122

Springer Publishing Company

Access to resources Recommend Favorite